ALB and neoplasm: Albumin coating of a range of synthetic nanocarriers has shown beneficial effects, including enhanced lipid membrane interactions, reduced toxicity, augmented receptor-mediated (gp60, gp30, gp18 and SPARC receptors) uptake in tumour cells30–36, and prolonged blood circulation37.